Most Recent
The deputy chairman of the Australian Securities and Investments Commission, Peter Kell, has resigned just five months into a yearlong extension of his contract with the corporate watchdog.
MyBudget has successfully fought off a class action brought by consumers who claimed the budget management firm violated consumer law by holding onto interest earned on their personal budgeting accounts.
Generic drug company Alphapharm has lost a bid for documents it claimed would show Sanofi-Aventis suspected as early as 2015 that patents for one of its injector pens may be invalid.
Australia needs stronger regulation to prevent the country's major airports from abusing their market power, the Australian Competition and Consumer Commission said Tuesday.
Hytera Communications has until Thursday to reveal what evidence has been or will be withheld from Motorola in their intellectually property battle in compliance with strict Chinese state security and cybersecurity laws.
A judge has said a case filed by Hyundai Engineering & Steel Industries to enforce a $7.9 million arbitration award against Alfasi Steel over the delayed construction of Sydney's International Conference Centre can move forward even though Alfasi has gone into administration.
Generic drug maker Dr Reddy's Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
In-house counsel at Glencore has been granted access to "highly confidential" documents related to the possible sale by Cargill of its Joe White malt business so that he can mull a settlement offer.
Mining tycoon Clive Palmer has succeeded in having a Queensland Supreme Court judge recused from a trial over the 2016 collapse of Queensland Nickel.
Prime Minister Scott Morrison has announced a royal commission into the aged care sector, saying he was moved to action by the "very disturbing trend" of non-compliance, abuse and failures in the industry.